CoChat

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

Open access
Cao, Yunlong, Yisimayi, Ayijiang, Bai, Yali, Huang, Weijin, Li, Xiaofeng, Zhang, Zhiying, Yuan, Tianjiao, An, Ran, Wang, Jing, Xiao, Tianhe, Du, Shuo, Ma, Wenping, Song, Liyang, Li, Yongzheng, Li, Xiang, Song, Weiliang, Wu, Jiajing, Liu, Shuo, Li, Xuemei, Zhang, Yonghong, Su, Bin, Guo, Xianghua, Wei, Yangyang, Gao, Chuanping, Zhang, Nana, Zhang, Yifei, Dou, Yang, Xu, Xiaoyu, Shi, Rui, Lu, Bai, Jin, Ronghua, Ma, Yingmin, Qin, Chengfeng, Wang, Youchun, Feng, Yingmei, Xiao, Junyu, Xie, Xiaoliang Sunney · 2021 · Cell Research
Cited by 146

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

SARS-CoV-2 variants could induce immune escape by mutations on the receptor-binding domain (RBD) and N-terminal domain (NTD). Here we report the humoral immune response to circulating SARS-CoV-2 variants, such as 501Y.V2 (B.1.351), of the plasma and neutralizing antibodies (NAbs) elicited by CoronaVac (inactivated vaccine), ZF2001 (RBD-subunit vaccine) and natural infection. Among 86 potent NAbs identified by high-throughput single-cell VDJ sequencing of peripheral blood mononuclear cells from vaccinees and convalescents, near half anti-RBD NAbs showed major neutralization reductions against the K417N/E484K/N501Y mutation combination, with E484K being the dominant cause. VH3-53/VH3-66 recurrent antibodies respond differently to RBD variants, and K417N compromises the majority of neutralizing activity through reduced polar contacts with complementarity determining regions. In contrast, the 242–244 deletion (242–244Δ) would abolish most neutralization activity of anti-NTD NAbs by interrupting the conformation of NTD antigenic supersite, indicating a much less diversity of anti-NTD NAbs than anti-RBD NAbs. Plasma of convalescents and CoronaVac vaccinees displayed comparable neutralization reductions against pseudo- and authentic 501Y.V2 variants, mainly caused by E484K/N501Y and 242–244Δ, with the effects being additive. Importantly, RBD-subunit vaccinees exhibit markedly higher tolerance to 501Y.V2 than convalescents, since the elicited anti-RBD NAbs display a high diversity and are unaffected by NTD mutations. Moreover, an extended gap between the third and second doses of ZF2001 leads to better neutralizing activity and tolerance to 501Y.V2 than the standard three-dose administration. Together, these results suggest that the deployment of RBD-vaccines, through a third-dose boost, may be ideal for combating SARS-CoV-2 variants when necessary, especially for those carrying mutations that disrupt the NTD supersite.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41422-021-00514-9

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 146

Metadata

Authors
Cao, Y., Yisimayi, A., Bai, Y., Huang, W., Li, X., Zhang, Z., Yuan, T., An, R., Wang, J., Xiao, T., Du, S., Ma, W., Song, L., Li, Y., Li, X., Song, W., Wu, J., Liu, S., Li, X., Zhang, Y., Su, B., Guo, X., Wei, Y., Gao, C., Zhang, N., Zhang, Y., Dou, Y., Xu, X., Shi, R., Lu, B., Jin, R., Ma, Y., Qin, C., Wang, Y., Feng, Y., Xiao, J., & Xie, X. S.
Venue
Cell Research
Published
2021-05-21
Volume
31
Issue
7
Pages
732-741
ISSN
  • 1001-0602 (ISSN-L)
  • 1748-7838
OpenAlex
W3183072827
Cited by
146
References
22
FWCI
9.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.